Actualités 17 Abr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 30 Abr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 17 Abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 03 Mayo 2024 QS lists half of Swiss subjects in global top 100 Only the USA and the UK rank higher than Switzerland in the QS World University Rankings 2024 for subjects listed in the top 10 worldwide. It's a...
News 06 Mayo 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 30 Abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 14 Feb 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 07 Ago 2023 CDR-Life receives milestone payment CDR-Life has reached a second milestone linked to the development of its drug to combat an irreversible retinal disease. This entitles the biotec...
News 04 Dic 2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
Aktuell 07 Ago 2023 CDR-Life erhält Meilensteinzahlung CDR-Life hat bei der Entwicklung seines Therapeutikums gegen eine irreversible Erkrankung der Netzhaut ein zweites Etappenziel erreicht. Das bere...
Aktuell 31 Ago 2023 Zahnmediziner verbinden Life Sciences und Gaming Zwei Wissenschaftler, die sich mit der Zellkommunikation in der oralen Medizin befassen, haben mit dem Game Technology Center der Eidgenössischen...
Aktuell 05 Mar 2024 Lucerne International School eröffnet neuen Campus in Root Die Lucerne International School eröffnet einen neuen Standort im D4 Business Village Conference Centre in Root. Die Feier zur Eröffnung findet a...
News 25 Oct 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 10 Ene 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 04 Ene 2024 Lucerne University of Applied Sciences and Arts to teach nursing at degree level Lucerne University of Applied Sciences and Arts will begin teaching degree-level nursing from the 2024 fall semester. It is also expanding its pr...
News 28 Mar 2024 Avallain agrees takeover of TeacherMatic Avallain has acquired the London-based firm TeacherMatic. With this takeover, the software specialist for education applications intends to expan...
News 20 Mar 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News 31 Ago 2023 Dentists combine life sciences and gaming Two scientists specializing in cell-to-cell communication in oral medicine have worked with the Game Technology Center at the Swiss Federal Insti...